Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

PATTI, Angelo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.667
EU - Europa 3.919
AS - Asia 2.851
SA - Sud America 509
Continente sconosciuto - Info sul continente non disponibili 462
AF - Africa 81
OC - Oceania 16
Totale 14.505
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.520
IT - Italia 1.302
SG - Singapore 1.049
RU - Federazione Russa 862
CN - Cina 683
BR - Brasile 377
DE - Germania 359
FI - Finlandia 355
VN - Vietnam 271
HK - Hong Kong 265
PL - Polonia 200
GB - Regno Unito 169
FR - Francia 151
UA - Ucraina 146
JP - Giappone 110
IE - Irlanda 105
IN - India 73
SE - Svezia 70
CA - Canada 67
BD - Bangladesh 65
KR - Corea 61
RO - Romania 37
AR - Argentina 35
IQ - Iraq 33
MX - Messico 33
TR - Turchia 31
AT - Austria 30
IR - Iran 27
MY - Malesia 24
BE - Belgio 23
ES - Italia 21
CI - Costa d'Avorio 20
CO - Colombia 20
EC - Ecuador 20
PK - Pakistan 19
TH - Thailandia 19
UZ - Uzbekistan 17
ZA - Sudafrica 17
NL - Olanda 16
CZ - Repubblica Ceca 15
SA - Arabia Saudita 15
AU - Australia 14
CL - Cile 14
VE - Venezuela 14
PH - Filippine 13
NP - Nepal 11
ID - Indonesia 10
CH - Svizzera 9
GR - Grecia 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 8
CR - Costa Rica 8
IL - Israele 8
JM - Giamaica 8
KE - Kenya 8
BG - Bulgaria 7
MA - Marocco 7
PE - Perù 7
DK - Danimarca 6
EG - Egitto 6
PY - Paraguay 6
HN - Honduras 5
JO - Giordania 5
TW - Taiwan 5
UY - Uruguay 5
AL - Albania 4
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
LB - Libano 4
LT - Lituania 4
PR - Porto Rico 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AO - Angola 3
AZ - Azerbaigian 3
GE - Georgia 3
GY - Guiana 3
NI - Nicaragua 3
PS - Palestinian Territory 3
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GD - Grenada 2
HT - Haiti 2
HU - Ungheria 2
LU - Lussemburgo 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
Totale 14.026
Salva come PNG Salva come JPEG
Città #
Ashburn 794
Singapore 735
Fairfield 556
San Jose 432
Chandler 407
Wilmington 255
Hong Kong 252
Woodbridge 251
Houston 227
Seattle 223
Council Bluffs 187
Cambridge 184
Ann Arbor 164
Zgierz 163
Palermo 153
Moscow 144
Beijing 128
Rome 113
Des Moines 109
Medford 109
Los Angeles 108
Tokyo 107
Dublin 104
Santa Clara 101
New York 98
Ho Chi Minh City 86
Dallas 83
Jacksonville 78
Lauterbourg 72
Milan 71
Princeton 69
Altamura 67
Nanjing 67
Frankfurt am Main 65
Boardman 61
Helsinki 59
Hanoi 55
Lawrence 51
San Diego 41
The Dalles 41
Chicago 40
São Paulo 37
Buffalo 35
Hefei 33
Jinan 30
London 30
Tulsa 26
Warsaw 26
Changsha 25
Dearborn 25
Nuremberg 24
Orem 24
Shenyang 24
Da Nang 22
Nanchang 22
Naples 21
Abidjan 20
Atlanta 20
Brooklyn 20
Brussels 20
Tianjin 20
Bangkok 19
Hebei 19
Redwood City 18
Baghdad 17
Columbus 17
Denver 17
Florence 17
Guangzhou 17
Munich 17
Ningbo 17
Rio de Janeiro 17
Ludwigshafen am Rhein 16
Phoenix 16
Tehran 16
Toronto 16
Boston 15
Montreal 15
Chennai 14
Haiphong 14
Poplar 14
Amsterdam 13
Bari 13
Johannesburg 13
San Francisco 13
Verona 13
Jiaxing 12
Kuala Lumpur 12
Brasília 11
Catania 11
Napoli 11
San Paolo di Civitate 11
Stockholm 11
Cardiff 10
Falls Church 10
Melbourne 10
Paris 10
Vienna 10
Brno 9
Cagliari 9
Totale 8.154
Salva come PNG Salva come JPEG
Nome #
PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD) 869
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 424
Autoimmune liver disease in a sicilian woman. 297
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 279
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 266
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 259
The Role of Nutraceuticals in Statin Intolerant Patients 258
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 251
REPORT OF A CASE OF MALIGNANT TUMOR-LIKE GASTRIC LESION BY CANDIDA IN A DIABETIC TREATED WITH CYCLOSPORINE FOR PSORIASIS AND REVIEW OF THE LITERATURE 250
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 250
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 238
Lichen sclerosus as a cause of recurrent cystitis: case report and review of the literatury. 235
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 232
Diagnostica non invasiva delle varici esofagee nei pazienti con cirrosi epatica: dati ecografici vs dati endoscopici 225
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 225
Osteodystrophy in chronic liver diseases. 224
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 223
Management of Statin Intolerance in 2018: Still More Questions Than Answers 222
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 217
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 215
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 212
Cloni di carciofo "Romanesco" in coltura annuale in Sicilia 210
Food hypersensitivity-associated irritable bowel syndrome: may fecal assays improve diagnosis? 200
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 197
The effect of bergamot on dyslipidemia 196
MALIGNANT TUMOR-LIKE GAASTRIC LESION DUE TO CANDIDA ALBICANS IN A DIABETIC PATIENT TREATED WITH CYCLOSPORIN: A CASE REPORT AND REVIEW OF THE LITERATURE 195
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 193
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 192
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 191
O- Alkylation of a lignite humic acid by phase-transfer catalysis 190
Improving diagnostic accuracy in Celiac Disease diagnosis: anti-endomysium antibody assay in colture medium of duodenal biopsies. 185
Malignant tumor-like gastric lesion by Candida albicans. 182
Improving diagnostic accuracy in celiac disease diagnosis: antiendomysium antibody assay in the culture medium of duodenal biopsies. 181
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 180
Food hypersensitivity in patients with irritable bowel syndrome: the diagnostic role of fecal assays. 179
Effects of Liraglutide on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with The Metabolic Syndrome: A 12-Month Prospective Pilot Study 178
Rare Candida albicans overgrowth in an immunosuppressed patient: case report of a malignant tumor-like gastric lesion. 176
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect 176
Nutraceuticals as an important part of combination therapy in dyslipidaemia 176
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study 173
Lichen sclerosus and atrophicus: report of a case of female patient affected with recurrent cystitis. 168
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 166
Anti-atherogenic Effects of 17β-Estradiol 165
Smoking and small, dense low-density lipoproteins. 162
Prevalence of antibodies anti-bartonella henselae in western Sicily: children, blood donors, cats 160
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 157
Advances in pharmacological treatment of type 1 diabetes during pregnancy 157
Variazioni emodinamiche del circolo epatico in pazienti con bright liver ecopattern e sindrome metabolica 153
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 152
INCRETIN-BASED THERAPIES, GLUCOMETABOLIC HEALTH AND ENDOVASCULAR INFLAMMATION 151
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 149
Serological, immunomorphological and bioinformatics analyses suggest Hsp60 is involved in Hashimoto’s thyroiditis pathogenesis. 148
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. 148
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 139
Natural approaches in metabolic syndrome management 137
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases 133
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. 131
PREVALENCE OF LIVER STEATOSIS AND FIBROSIS AND RELIABILITY OF ULTRASOUND IN DETECTING NAFLD IN OBESE PATIENTS 125
Metabolic disorders during pregnancy and postpartum cardiometabolic risk 120
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 119
Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. 118
Future perspectives of the pharmacological management of diabetic dyslipidemia 117
Novel therapeutical approaches to managing atherosclerotic risk 116
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes 115
NUOVE STRATEGIE PER IL MANAGEMENT CLINICO, DIAGNOSTICO E TERAPEUTICO DELLE MALATTIE CARDIO-METABOLICHE 111
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 110
Pharmacotherapy for gestational diabetes 107
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update 101
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes 100
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus 97
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? 93
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies 89
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 88
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies 87
Oxidative stress and small, dense low-density lipoproteins: Current and future perspectives 87
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes 77
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome 70
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review. 66
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes 66
Obesity and HFpEF 64
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? 59
Impact of different hormones on the regulation of nitric oxide in diabetes 49
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance 49
Short-term nutraceutical efficacy of Glucoerb® and Epavin® in overweight and obese adults: a 3-month observational study 29
Real-world effectiveness of 6-month tirzepatide therapy on body weight and composition in adults with overweight or obesity 24
Anti-obesity innovative therapies improve atherogenic lipoproteins and inflammatory biomarkers in adults with overweight or obesity: a 3-month prospective study 22
Artificial intelligence-based retinal screening and ocular parameters in cardiometabolic disease: an ophthalmologist-confirmed RWE study 19
Artificial intelligence-based retinal screening for cardiometabolic prevention: a 3-month real-world evidence study 14
Totale 14.505
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.015
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022694 0 0 40 32 23 38 35 76 92 140 66 152
2022/20231.411 135 211 30 135 126 191 126 120 151 37 91 58
2023/2024681 35 91 53 43 44 143 85 37 20 18 34 78
2024/20251.558 29 172 113 143 67 55 116 80 116 168 183 316
2025/20265.016 344 158 252 456 548 694 666 518 442 573 129 236
2026/20271.127 322 299 506 0 0 0 0 0 0 0 0 0
Totale 14.505